Back to Research

Organization profile

Cimeio Therapeutics

[Confidence Level: High] Cimeio Therapeutics is a Swiss-based therapeutics organization developing Shielded-Cell & Immunotherapy Pairs™ (SCIP), a proprietary platform designed to transform the treatment of hematologic diseases by genetically shielding healthy hematopoietic stem cells (HSCs) from targeted immunotherapies.1

Basel, SwitzerlandFounded 2022

Overview

[Confidence Level: High] Cimeio Therapeutics is a Swiss-based therapeutics organization developing Shielded-Cell & Immunotherapy Pairs™ (SCIP), a proprietary platform designed to transform the treatment of hematologic diseases by genetically shielding healthy hematopoietic stem cells (HSCs) from targeted immunotherapies.1

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.